Riskpilot← Back to searchSign inGet full accessConvaTec Oy
OYActiveY-tunnus 1644589-9Karhumäentie 3Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2000— employees
Revenue 2024
EUR 8M
+1% vs 2023
EBITDA margin
2.7%
+65% vs 2023
Equity ratio
30.8%
Financial strength
Net profit 2024
EUR 219K
+44% vs 2023
| Revenue | EUR 8M | +1% |
| EBITDA | EUR 214K | +65% |
| Net profit | EUR 219K | +44% |
| Total assets | EUR 3,7M | — |
| Equity | EUR 1,1M | -92% |
| Employees | — | — |
Legal name
ConvaTec Oy
Y-tunnus number
1644589-9
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28. joulukuuta 2000
Share capital
EUR 450 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsen yksin
Company purpose
Föremålet för bolagets verksamhet är att bedriva tillverkning, marknadsföring och försäljning av hälso- och sjukvårdsprodukter, samt annan därmed förenlig verksamhet.
Address
Karhumäentie 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 10 418 | 10 215 | 10 743 | 7 856 | 7 962 |
| Staff expenses | −1 794 | −1 222 | −1 308 | −1 198 | −1 151 |
| EBITDA | 272 | 372 | 330 | 130 | 214 |
| Depreciation & amort. | −11 | −10 | −7 | −3 | −0 |
| EBIT | 261 | 362 | 323 | 127 | 214 |
| Net financials | −0 | −18 | −13 | 66 | 52 |
| Profit before tax | 261 | 344 | 311 | 193 | 266 |
| Tax | 32 | 62 | 64 | 41 | 47 |
| Net profit | 229 | 282 | 247 | 152 | 219 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 584 | 2 909 | 5 028 | 0 | 3 722 |
| Equity | 1 995 | 1 277 | 1 523 | 15 247 | 1 145 |
| Long-term debt | 251 | 148 | 122 | 0 | 0 |
| Short-term debt | 2 338 | 1 484 | 3 383 | 0 | 2 577 |
| Total debt | 2 589 | 1 632 | 3 505 | 0 | 2 577 |
EBITDA margin
2.7%
This company
15.8%
Market median
-83% vs market
20202024
Equity ratio
30.8%
This company
38.2%
Market median
+19% vs market
20202024
Return on equity
19.1%
This company
18.4%
Market median
+4% vs market
20202024
Net profit margin
2.8%
This company
8.1%
Market median
-65% vs market
20202024
Asset turnover
2.14×
This company
1.12×
Market median
+91% vs market
20202024
Debt / equity
2.25×
This company
0.62×
Market median
-263% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
KM Audit | Audit | 2019 – 2023 |
JW Person with significant control | Person with significant control | 2020 – 2021 |
KA Person with significant control | Person with significant control | 2018 – 2020 |
JS | Audit | 2017 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2026 | |
| Chairperson | 2022 | |
| Former (3) | ||
| Board of Directors | 2017 – 2021 | |
| Board of Directors | 2017 – 2021 | |
| Board of Directors | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ConvaTec Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kati Maarit Kareinen | Audit | 0 companies |
| Jens Waldemar Bøegh | Person with significant control | 0 companies |
| Katarzyna Anna Hammar | Person with significant control | 0 companies |
| Jussi Sakari Lahtinen | Audit | 0 companies |
| Michael Christian Remy Jensen | Board of Directors | 0 companies |
| Behrouz Afshari Vafa | Board of Directors | 0 companies |
| Satu Minna Marjukka Lindqvist | Board of Directors | 0 companies |
| Milla Anneli Sola | Board of Directors | 0 companies |
| Mark Edward Warren | Chairperson | 0 companies |
| Riitta Maria Suhonen | Board of Directors | 0 companies |